Related Experiment Video
Updated: Aug 18, 2026

Lung Rapid Recovery Procurement Combined with Abdominal Normothermic Regional Perfusion in Controlled Donation after Circulatory Death
Published on: August 15, 2022
Transfusion related acute lung injury: a pediatric perspective
1Department of Pediatrics, University of California-San Francisco, 505 Parnassus Street, San Francisco, CA 94143, USA. rsanchez@itsa.ucsf.edu
Insights
Transfusion-related acute lung injury (TRALI) is a critical risk in pediatric patients, particularly those with hematologic malignancy. Early recognition and reporting are vital for diagnosis and donor identification in transfusion-associated respiratory distress.
Area of Science:
- Pediatric Hematology
- Critical Care Medicine
- Transfusion Medicine
Background:
- Transfusion-related acute lung injury (TRALI) is the primary cause of mortality associated with blood transfusions.
- While TRALI affects both children and adults, a comprehensive pediatric-focused review is lacking.
- TRALI is increasingly recognized in pediatric populations, especially in those with hematologic malignancies.
Purpose of the Study:
- To review the existing literature on TRALI specifically from a pediatric perspective.
- To highlight the incidence and characteristics of TRALI in children.
- To emphasize the importance of considering TRALI in pediatric patients with acute respiratory complications post-transfusion.
Main Methods:
- A comprehensive literature review was conducted focusing on pediatric TRALI cases.
- Studies documenting TRALI in children across various diagnoses were analyzed.
- The review synthesized findings on TRALI presentation, risk factors, and outcomes in pediatric patients.
Main Results:
- TRALI has been documented in pediatric patients, with a notable prevalence in those with hematologic malignancy.
- Cases of TRALI have been reported in children with diverse medical conditions.
- The incidence of TRALI in the pediatric population may be significantly underestimated.
Conclusions:
- TRALI should be a key consideration in the differential diagnosis for any pediatric patient developing acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) shortly after a blood transfusion.
- Prompt reporting of suspected TRALI cases to the blood bank is crucial for investigation and identification of the implicated donor.
- Increased awareness and vigilance are necessary to accurately diagnose and manage TRALI in pediatric patients.
Abstract:
Transfusion-related acute lung injury (TRALI) is the leading cause of transfusion-associated mortality. TRALI occurs in children and adults, but the syndrome has not been reviewed from a pediatric perspective. We reviewed the literature on TRALI from a pediatric perspective. TRALI has been documented in pediatric patients, especially in the setting of hematologic malignancy. Additional TRALI cases have been reported in pediatric patients with a variety of diagnoses. TRALI is likely to be much more common than previously appreciated in the pediatric patient population. TRALI should be considered in the differential diagnosis of all pediatric patients who develop new acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) during or within six hours of a blood product transfusion. When a case of TRALI is suspected, a transfusion reaction report to the blood bank is important to initiate the investigation and identify the implicated donor.
Related Concept Videos
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Acute Respiratory Failure-I
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Pulmonary Cycle: Exhalation
Acute Respiratory Failure-IV
